John J. Worthington III, MD

  • 2Articles
  • 5KReads
  • 2005–2006Active
  • 12Collaborators

About

John J. Worthington III, MD, has published research focused on pharmacological augmentation strategies for treatment-resistant psychiatric conditions. His work includes studies on risperidone augmentation in refractory anxiety disorders and aripiprazole augmentation of selective serotonin reuptake inhibitors in major depressive disorder. His articles appeared in Psychiatrist.com between 2005 and 2006.

Publications

JCP
JCP

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.